Consistent with prior studies, our results revealed that knocking out BIN1 in tumor cells significantly enhances the development of NSCLC both in vitro and in vivo, underscoring the role of reduced BIN1 expression in driving cancer progression. This evidence concerns the gene BIN1 and neoplasm.